Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
95 hedge funds and large institutions have $824M invested in Epizyme, Inc in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 19 reducing their positions, and 21 closing their positions.
137% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 19
84% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $776K
39% more capital invested
Capital invested by funds: $593M → $824M (+$231M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
8% less funds holding
Funds holding: 103 → 95 (-8)
38% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$28.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.7M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.65M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.92M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$7.37M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.89M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.3M |
| 4 |
QF
QVT Financial
New York
|
-$4.24M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$4.12M |
EPZM Hedge Fund Activity: Q2 2015 in Review
95 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2015, worth a combined $824M — up 39% from $593M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of EPZM and 13 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 45 added.
The largest buyer was State Street, adding an estimated $28.6M. The largest seller was MPM Asset Management, cutting an estimated $7.37M.
- 95 institutional investors held Epizyme, Inc (EPZM) as of Q2 2015, down from 103 in Q1 2015.
- Funds reported $824M of Epizyme, Inc stock for Q2 2015, up 39% quarter-over-quarter.
- 13 funds opened new Epizyme, Inc positions in Q2 2015 and 21 closed out, a net change of -8 holders.
- The largest Epizyme, Inc buyer in Q2 2015 was State Street, an estimated $28.6M added.
- The largest Epizyme, Inc seller in Q2 2015 was MPM Asset Management, an estimated $7.37M sold.
Based on aggregated 13F filings for Q2 2015.